Federated Hermes, Inc. 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-08 09:10 am Sale | 2024-03-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 95,000 0.110% | -10,621,153 (-99.11%) | Filing |
| 2024-03-25 5:29 pm Sale | 2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,716,153 12.650% | -170,000 (-1.56%) | Filing |
| 2024-01-18 10:11 am Purchase | 2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,886,153 15.030% | 252,364 (+2.37%) | Filing |
| 2023-06-09 08:19 am Purchase | 2023-05-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,633,789 16.660% | 7,409,689 (+229.82%) | Filing |
| 2023-02-01 08:56 am Purchase | 2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 3,224,100 7.200% | 3,224,100 (New Position) | Filing |